Literature DB >> 8245544

Diagnosis of Helicobacter pylori infection in a developing country: comparison of two ELISAs and a seroprevalence study.

L Bodhidatta1, C W Hoge, S Churnratanakul, W Nirdnoy, P Sampathanukul, C Tungtaem, S Raktham, C D Smith, P Echeverria.   

Abstract

Serology to detect antibodies to Helicobacter pylori is not frequently used as a diagnostic tool in developing countries. When compared to a commercial ELISA, an ELISA constructed and validated in Thailand had a higher sensitivity (98% vs. 85%), specificity (76% vs. 66%), and negative predictive value (97% vs. 76%) for the detection of H. pylori infection among 104 patients with dyspepsia evaluated by endoscopy. The positive predictive value was 88% for both tests. Serum antibody levels fell significantly 5-8 months after eradication of infection in 8 Thai patients (P = .009). By 8 years of age, > 50% of Thai persons living in urban and rural locations were seropositive. The low negative predictive value of the commercial ELISA limits the usefulness of this assay as a diagnostic tool in Thailand and suggests a need to reevaluate H. pylori serologic tests when used in populations living in developing countries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245544     DOI: 10.1093/infdis/168.6.1549

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Validation of serological tests for Helicobacter pylori infection in an Irish population.

Authors:  N P Breslin; J M Lee; M J Buckley; E Balbirnie; D Rice; C A O'Morain
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  Evaluation of commercial immunoassays for detection of antibody against Helicobacter pylori in Thai dyspeptic patients.

Authors:  Orrawadee Hanvivatvong; Atinop Pongpanich; Duangporn Thong-Ngam; Niramol Thammacharoenrach; Pinit Kullavanijaya
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

3.  Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori.

Authors:  A E Simor; E Lin; F Saibil; L Cohen; M Louie; S Pearen; H A Donhoffer
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 4.  Evaluation of commercially available Helicobacter pylori serology kits: a review.

Authors:  R J Laheij; H Straatman; J B Jansen; A L Verbeek
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Comparison of two rapid whole-blood tests for Helicobacter pylori infection in Chinese patients.

Authors:  W K Leung; F K Chan; M S Falk; R Suen; J J Sung
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

6.  Comparison of rapid office-based serology with formal laboratory-based ELISA testing for diagnosis of Helicobacter pylori gastritis.

Authors:  J A Kroser; D O Faigel; E E Furth; D C Metz
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

7.  Antigenic characterization of Helicobacter pylori strains from different parts of the world.

Authors:  J Höök-Nikanne; G I Perez-Perez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

8.  Diagnosis of Helicobacter pylori infection in a colony of rhesus monkeys (Macaca mulatta).

Authors:  L K Handt; J G Fox; L L Yan; Z Shen; W J Pouch; D Ngai; S L Motzel; T E Nolan; H J Klein
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

9.  Intra-familial transmission of Helicobacter pylori infection in children of households with multiple generations in Vietnam.

Authors:  Van Bang Nguyen; Gia Khanh Nguyen; Dac Cam Phung; Karen Okrainec; Josette Raymond; Christophe Dupond; Odile Kremp; Nicolas Kalach; Gwenaelle Vidal-Trecan
Journal:  Eur J Epidemiol       Date:  2006-07-07       Impact factor: 8.082

10.  Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated.

Authors:  Thi Thu Ha Hoang; Thuc-Uyen Wheeldon; Carina Bengtsson; Dac Cam Phung; Mikael Sörberg; Marta Granström
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.